GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Median PS Value

Fisher & Paykel Healthcare (NZSE:FPH) Median PS Value : NZ$21.55 (As of May. 01, 2024)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Fisher & Paykel Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$2.933. Fisher & Paykel Healthcare's 10-Year median PS Ratio is 7.3474. Therefore, the Median PS Value for today is NZ$21.55.

As of today (2024-05-01), Fisher & Paykel Healthcare's share price is NZ$28.21. Fisher & Paykel Healthcare's Median PS Value is NZ$21.55. Therefore, Fisher & Paykel Healthcare's Price to Median PS Value for today is 1.31.

The historical rank and industry rank for Fisher & Paykel Healthcare's Median PS Value or its related term are showing as below:

NZSE:FPH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.98   Med: 1.46   Max: 2.24
Current: 1.31

During the past 13 years, the highest Price to Median PS Value of Fisher & Paykel Healthcare was 2.24. The lowest was 0.98. And the median was 1.46.

NZSE:FPH's Price-to-Median-PS-Value is ranked worse than
82.22% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 0.78 vs NZSE:FPH: 1.31

Fisher & Paykel Healthcare Median PS Value Historical Data

The historical data trend for Fisher & Paykel Healthcare's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Median PS Value Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.44 13.52 22.88 21.05 21.55

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 21.05 - 21.55 -

Competitive Comparison of Fisher & Paykel Healthcare's Median PS Value

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Price-to-Median-PS-Value falls into.



Fisher & Paykel Healthcare Median PS Value Calculation

Fisher & Paykel Healthcare's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=2.933*7.3474
=21.55

10-Year Median PS Ratio is 7.3474.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$2.933.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Fisher & Paykel Healthcare's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=28.21/21.55
=1.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare Median PS Value Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.